Clinical Trials in Caserta, CE
7 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 3
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Novartis Pharmaceuticals340 enrolled92 locationsNCT06813911
Recruiting
Phase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Aortic Stenosis
Novartis Pharmaceuticals502 enrolled139 locationsNCT05646381
Recruiting
European Unified Registries for Heart Care Evaluation and Randomised Trials Italy
ACS (Acute Coronary Syndrome)
Heart Care Foundation5,000 enrolled57 locationsNCT07283809
Recruiting
Phase 2
ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer
Colorectal Cancer Metastatic
National Cancer Institute, Naples130 enrolled8 locationsNCT06714357
Recruiting
Not Applicable
Integrated Approach in Frail Older People with Atrial Fibrillation
Heart FailureDiabetes MellitusHypertension+7 more
Heart Care Foundation1,250 enrolled50 locationsNCT06775028
Recruiting
BRING-UP 3 Heart Failure
Heart Failure
Heart Care Foundation10,000 enrolled187 locationsNCT06279988
Recruiting
BRING-UP Prevention
Peripheral Arterial DiseaseCerebrovascular DisordersIschemic Heart Disease
Heart Care Foundation6,000 enrolled196 locationsNCT06275113